Table 1. Correlation between SFTA1P expression and clinicopathological characteristics of GC patients.
| Characteristics | n (%) | SFTA1P | P | |
|---|---|---|---|---|
| Low NO. cases (34) | High NO. cases (34) | Chi-squared test P-value | ||
| Gender | 0.806 | |||
| Male | 39 (57.4%) | 19 | 20 | |
| Female | 29 (42.6%) | 15 | 14 | |
| Age | 0.329 | |||
| ≤65 | 30 (44.1%) | 13 | 17 | |
| ≥65 | 38 (55.9%) | 21 | 17 | |
| Stage | 0.002* | |||
| I + II | 33 (48.5%) | 10 | 23 | |
| III | 35 (51.5%) | 24 | 11 | |
| Lymph node metastasis | 0.029* | |||
| Negative | 33 (48.5%) | 12 | 21 | |
| Positive | 35 (51.5%) | 22 | 13 | |
| Tumor size | 0.026* | |||
| ≤5 cm | 27 (39.7%) | 9 | 18 | |
| >5 cm | 41 (60.3%) | 25 | 16 | |
*
P-value<0.05 was considered significant.